This weekend at the ASH Meeting on Hematological Malignancies (ASHMHM15), Lymphoma Program Director, Dr. John Leonard will discuss how he treats patients with mantle cell lymphoma, and specifically on how to overcome mantle cell lymphoma resistance to ibrutinib.
Author: lymphomaprogram
Located on the Upper East Side of New York City, the Lymphoma Program at Weill Cornell Medical College/NewYork Presbyterian Hospital is internationally recognized for our efforts to enable patients with non-Hodgkin lymphoma, Hodgkin disease and related disorders to have the best possible clinical outcome, including cure when possible.
#LightitRed for World Lymphoma Awareness Day
September 15th is World Lymphoma Awareness Day (#WLAD) a day dedicated to raising awareness of lymphoma. As part of this effort our lymphoma clinicians and researchers participated in the Lymphoma Research Foundation’s #LightitRed campaign to raise lymphoma awareness.
REDLAMP 10: Can Physical Activity Lower the Risk of Non-Hodgkin Lymphoma?
The association between physical activity and a lower risk of non-Hodgkin lymphoma is not well proven and few studies have established any link. However, Cancer Epidemiology, Biomarkers & Prevention published results from a case controlled study on physical activity and the risk of non-Hodgkin lymphoma. In this video Dr. Peter Martin explains the rationale of this case study, its findings, and important takeaways for people who may be at risk for non-Hodgkin lymphoma.
Previous #REDLAMP entries can be viewed on our Youtube channel.
We encourage you to follow the Lymphoma Program on Twitter, Youtube, and Facebook where we will highlight new videos are about research publications as they are released. We also welcome your feedback, suggestions and questions about this project. If you have other questions about our lymphoma program or clinical trials or would like to see one of our lymphoma specialists, please contact us at 212-746-2919.
New Developments in Lymphoma 